Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

Blood Cancer Journal, Published online: 07 March 2023; doi:10.1038/s41408-023-00805-xDaratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

Source: Blood Cancer Journal - March 7, 2023 Category: Hematology Authors: Philippe Moreau Ajai Chari Albert Oriol Joaquin Martinez-Lopez Mathias Haenel Cyrille Touzeau Sikander Ailawadhi Britta Besemer Javier de la Rubia Comos Cristina Encinas Maria-Victoria Mateos Hans Salwender Paula Rodriguez-Otero Cyrille Hulin Lionel Karli Source Type: research